This is a quality controlled, peer-reviewed, open access INTERNATIONAL journal. Archives of Medicine publish research reports, and articles of various research processes like study protocols, pilot studies and pre-protocols. Chloroquine hyperpigmentation pictures face Is hydroxychloroquine an opioid Does plaquenil cause bleeding Exacerbation of Psoriasis due to Hydroxychloroquine Sara S McCoy1*, Vivek Nagaraja2, Scott Paviol3, Johann E Gudjonsson4 and J Michelle Kahlenberg1 1 Department of Internal Medicine, Di-vision of Rheumatology, University of Michigan, USA 2 Department of Internal Medicine, Division of Rheumatology, University of Toledo, USA Background Antimalarials have been reported to worsen preexisting psoriasis, therefore is commonly avoided by the clinicians in the treatment of psoriatic arthritis PsA. With the lack of any solid evidence, this precludes the potential use of hydroxychloroquine HQ as a part of the treatment. Interest in hydroxychloroquine treatment of psoriatic arthritis has been revived because of recent series found no exacerbation of psoriatic skin lesions in 50 psoriatic arthropathy patients treated with hydroxychloroquine. A psoriatic arthropathy patient whose skin lesions were markedly exacerbated by hydroxychloroquine is reported. Subject areas include studies in fields of immunology, anesthesia, cardiovascular medicine, complementary medicine, dentistry and oral medicine, pathology, pharmacology and therapeutics, dermatology, respiratory medicine, rheumatology, drugs and medicines, ear, nose and throat/otolaryngology, emergency medicine, infectious diseases, neurology, nutrition and metabolism, obstetrics and gynaecology, endocrinology, gastroenterology, genetics, geriatric medicine, haematology, oncology, ophthalmology, paediatrics, psychiatry, radiology, renal medicine, pharmacognosy, sexual health, urology, epidemiology, ethnic studies, health policy, occupational health, medical education, legal and forensic medicine, environmental medicine and public health, medicine development and safety testing, drug legislation and safety. The journal is novel, attractive, open minded, and a peer-reviewed medical periodical designed to serve as a platform for both veteran and ammeter researchers with their path breaking works as long as they are technically correct and scientifically motivated. Hydroxychloroquine for psoriasis Hydroxychloroquine Uses, Dosage & Side Effects -, AB0827 Hydroxychloroquine Does not Increase Psoriasis in. Plaquenil sun reactionHydroxychloroquine arthritis research uk Plaquenil is the brand name for the prescription drug hydroxychloroquine. It's used to treat and prevent malaria infection, and to reduce symptoms and progression of autoimmune diseases such as. Plaquenil Hydroxychloroquine - Side Effects, Dosage.. Hydroxychloroquine in psoriatic arthropathy exacerbations.. PDF Hydroxychloroquine in Psoriasis Is it Really Harmful?. Psoriasis skin disease or Stomach or bowel problems–Use with caution. May make these conditions worse. Glucose-6-phosphate dehydrogenase G6PD deficiency—May cause hemolytic anemia in patients with this condition. Kidney disease or Liver disease—Use with caution. Dosage for Plaquenil. The adult dose of Plaquenil to suppress malaria is 400 mg on the same day each week. The pediatric weekly suppressive dosage is 5 mg/kg of body weight. The adult dose of Plaquenil to treat an acute attack of malaria is an initial dose of 800 mg followed by 400 mg in six to eight hours and 400 mg for two more days. Hydroxychloroquine is a prescription drug. It comes as an oral tablet. Hydroxychloroquine is available as the brand-name drug Plaquenil. It’s also available in a generic version.